Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 126Unknown 21Terminated 20Recruiting 18Active not recruiting 5Withdrawn 3Not yet recruiting 3Suspended 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 35Breast Neoplasms 30Prostatic Neoplasms 22Leukemia, Myeloid, Acute 20Colorectal Neoplasms 20Melanoma 17Pancreatic Neoplasms 16Glioblastoma 16Carcinoma, Non-Small-Cell Lung 16Neoplasm Metastasis 15Lung Neoplasms 13Brain Neoplasms 13Glioma 12Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Carcinoma, Hepatocellular 11Ovarian Neoplasms 10Multiple Myeloma 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma 8Carcinoma, Renal Cell 8Leukemia 7Sarcoma 6Rectal Neoplasms 6Hematologic Neoplasms 6Esophageal Neoplasms 6Uterine Cervical Neoplasms 5Recurrence 5

Interventions

Ifosfamide 1Amblyomin-X protein, Amblyomma cajennense 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Interventional × Advanced Cancer × Clear all
NCT03120130 2019-10-14

Amblyomin-X

União Química Farmacêutica Nacional S/A

Phase 1 Suspended
24 enrolled

Advanced Cancer

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended
20 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡